Search results

Since the early 1980s, the Chinese government has been driving the evolution of an endogenous innovation system. Various policies were adopted to foster the improvement of technological capabilities in the past two decades. The characteristics of the Chinese innovation system have been gradually reshaped. Such structural evolution affects the development of the Chinese biotechnology industry as well. The purpose of this study is to investigate the significance of the changes in the Chinese innovation system for biotechnology transfer. Three major trends have been discerned. First, the enhancement of a patent system has provided a vehicle for innovators to convert knowledge into marketable formats. Filing for patent protection is becoming an ordinary practice across industries. Second, the formalization of the business contract system has demonstrated great effect on the user-producer interactions between international biotechnology firms & their Chinese counterparts. Third, biotechnology research has become one of the most popular industries in China. Due to the increasing mobility of the research & development (R&D) workforce & the restructuring of the R&D financing scheme, scientists & engineers are able to work where their knowledge is valued & needed most. Also, the concentration of research manpower & funds may encourage the positive feedback of China's biotechnology innovation system. International technology transfer can be an effective strategy to engage this positive cycle. 5 Tables, 1 Chart. Adapted from the source document.

This study examines the influence of green creativity to the green new product performances. Creativity is a key source of organization's competitive advantage (Barney, 1991) and increases the likelihood of new product success by providing effective product differentiation (Song, 2018). Building on the thesis of Natural Resource-based view (Hart, 1995), we study the impact of green creativity on the performances of green new products. This study also shows that family involvement plays a role in the green performances of family businesses. We pay particular attention to family firms because of two reasons. First, family businesses represent a significant proportion of the corporate sector in both developed and developing countries (Faccio and Lang 2002). Second, family firms have different behavioral patterns when reacting to stakeholders' pressures (Huaang, Ding, and Kao, 2009; Sharma and Sharma, 2011) for better environmental management practices. This study surveyed 134 family-owned, high-tech manufacturers in Taiwan. The findings show that the green creativity is positively and significantly related to green new product performances. Our analytical results also show that family involvement moderates the relationship between green creativity and green new product performances.

Recently, the interests in the performance of family firms in the capital market are on the rise. However studies on long-term performance give us little information about the performance of family firms in the initial public offering (IPO) markets. Building on agency theory, we investigated the effect of three IPO signals in family firm IPOs. Practices such as the appointment of outside non-family directors and waiting longer before going public significantly reduce underpricing. In addition, family owners' intent to retain large percentage of share in the long run is an indication of original shareholders' level of confidence in their own companies. Such confidence helps reduce after market investors' uncertainty and thus underpricing. On the other hand, family ownership at the IPO positively moderates the impact of non-family directors on underpricing.

Today, we know relatively well about what should be taught in the entrepreneurship program for non-business majors. However, our understanding of how should the non-business students be taught is still limited. To address this issue, we study the entrepreneurship curriculum developed for students in the Nontraditional Doctor of Pharmacy (NTPD) program at the University of Maryland Baltimore. In principle, the core of this entrepreneurship curriculum resembles a typical business school entrepreneurship course with an emphasis on developing a business or a project plan at the end of a two-semester, six-credit course sequence. This entrepreneurship curriculum for PharmD has a successful track record. From 1995 to 2003; 35% to 40% of the business plans developed by the NTPD students have been successfully funded. Although the program is structured in a similar manner as many other short-term entrepreneurship curricula in non-business programs, its implementation and dialectic approach create a dynamic learning environment that has effectively assisted non-business major graduate students to engage in business venturing activities. The infusion of dialectical inquiry at the NTPD program enables clinical pharmacy students to exploit their professional expertise while developing competence in business planning. Students are expected to plan for the implementation of some new aspect of clinical pharmacy into a new or existing practice. In this research, we reported the design of NTPD entrepreneurship curriculum and the training of business planning. Given the lack of foundation business knowledge and course time limitation in NTPD (and other hybrid programs), we posit that the effective implementation of dialectical inquiry will help students improve the quality of new venture planning.